These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
174 related articles for article (PubMed ID: 11444247)
1. Online laetrile vendor ordered to shut down. Lewis C FDA Consum; 2001; 35(2):37-8. PubMed ID: 11444247 [No Abstract] [Full Text] [Related]
2. Laetrile--of choice and effectiveness. Cooper RM Food Drug Cosmet Law J; 1983 Oct; 38(4):417-40. PubMed ID: 16100796 [No Abstract] [Full Text] [Related]
3. Technology: drug and device export reform. Betz R J Healthc Resour Manag; 1995 Oct; 13(10):30, 33. PubMed ID: 10151686 [No Abstract] [Full Text] [Related]
4. Laetrile: the making of a myth. FDA Consum; 1976 Dec-1977 Jan; 10(10):5-8. PubMed ID: 10304521 [No Abstract] [Full Text] [Related]
5. Laetrile and liberty. Zimmerly JG Leg Aspects Med Pract; 1978 Oct; 6(10):10. PubMed ID: 750806 [No Abstract] [Full Text] [Related]
6. Laetrile--fact or myth? Manfredi JA J Med Assoc Ga; 1976 May; 65(5):159-60. PubMed ID: 932581 [No Abstract] [Full Text] [Related]
7. GATT implementation and generic drug approval. Safir PO; Lassman SM Food Drug Law J; 1996; 51(2):295-302. PubMed ID: 11820203 [No Abstract] [Full Text] [Related]
8. Laetrile--its current status. Med Times; 1980 Dec; 108(12):36-45. PubMed ID: 7442493 [No Abstract] [Full Text] [Related]
9. New US agent requirements. Donawa M Med Device Technol; 2002; 13(1):35-7. PubMed ID: 11921780 [TBL] [Abstract][Full Text] [Related]
10. Drug marketing exclusivity under United States and European Union law. Junod V Food Drug Law J; 2004; 59(4):479-518. PubMed ID: 15875347 [No Abstract] [Full Text] [Related]
11. If your patients ask about laetrile. Med Times; 1977 Jun; 105(6):(80) 3d-8d. PubMed ID: 875673 [No Abstract] [Full Text] [Related]
12. [Laetrile, is it or is it not a miracle drug against cancer?]. Prins ME; Mulder JH Ned Tijdschr Geneeskd; 1979 Jul; 123(27):1141-4. PubMed ID: 460466 [No Abstract] [Full Text] [Related]
13. Appeals court approves laetrile use by terminally ill cancer patients. Am Med News; 1978 Jul; 21(28):1, 10. PubMed ID: 10308640 [No Abstract] [Full Text] [Related]
14. Potential legal barriers to increasing CMS/FDA collaboration: the law of trade secrets and related considerations. Wang SS; Smith JJ Food Drug Law J; 2003; 58(4):613-27. PubMed ID: 15027453 [No Abstract] [Full Text] [Related]
15. Laetrile in historical perspective. Young JH Conn Med; 1979 Aug; 43(8):497-500. PubMed ID: 399880 [No Abstract] [Full Text] [Related]
16. Laetrile and the privacy right in decisional responsibility. Volzer HJ Med Trial Tech Q; 1980; 26(4):395-429. PubMed ID: 7402007 [No Abstract] [Full Text] [Related]
17. The courts, terminal patients, and unapproved drugs. Janssen W FDA Consum; 1979 Nov; 13(9):4-7. PubMed ID: 10309109 [TBL] [Abstract][Full Text] [Related]
18. Laetrile: unsafe and ineffective--and illegal? McMeekin RR Leg Aspects Med Pract; 1978 Dec; 6(12):15-25. PubMed ID: 748685 [No Abstract] [Full Text] [Related]
20. Branded drug reformulation: the next brand vs. generic antitrust battleground. Amoresano GV Food Drug Law J; 2007; 62(1):249-56. PubMed ID: 17444032 [No Abstract] [Full Text] [Related] [Next] [New Search]